The fact that PD-L1 DNA methylation status does not inevitably mirror the expression level is important for future attempts to improve the effectiveness of PD-1/PD-L1 immunotherapy in NSCLC. The gene discussed is PDCD1; the disease is non-small cell lung carcinoma.